BGLC BioNexus Gene Lab Corp - Common stock
$1,57
Preço · Ago 19, 2026
Fundamentais a partir de Ago 14, 2026
Intervalo 52 Semanas
$1–$6
10% of range
Classificação do Analista
—
Preço-Alvo
—
P/E (TTM)
-1.0
ROE
-37.0%
Margem de Lucro Líquido
-40.2%
BGLC Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$1.57
Capitalização de Mercado
$4M
P/E (TTM)
-1.0
EPS (TTM)
$-0.09
Receita (TTM)
$7M
Rendimento div.
—
ROE
-37.0%
Dívida/Capital
—
Intervalo 52 Semanas
$1 – $6
BGLC Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
$7M
2018-12-31
→
2025-12-31
EPS
$-0.09
2023-12-31
→
2024-12-31
Fluxo de caixa livre
$-2M
2019-12-31
→
2025-12-31
Margens
-40.2%
2019-12-31
→
2025-12-31
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
BGLC
Mediana de Pares
P/E (TTM)
-1.0
12.4
P/S (TTM)
0.5
0.5
P/B
0.4
1.1
Price / FCF (Preço / FCF)
-2.0
—
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
BGLC
Mediana de Pares
Gross Margin (Margem Bruta)
14.6%
26.1%
Operating Margin (Margem Operacional)
-39.9%
—
Net Profit Margin (Margem de Lucro Líquido)
-40.2%
-2.7%
ROA
-30.3%
-5.6%
ROE
-37.0%
-20.3%
ROIC
-34.4%
—
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
BGLC
Mediana de Pares
Current Ratio (Índice de liquidez corrente)
10.5
1.3
Quick Ratio (Índice de Liquidez Seca)
5.7
—
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
BGLC
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
-21.9%
—
Revenue CAGR 3Y (CAGR Receita 3A)
-12.1%
—
Revenue CAGR 5Y (CAGR Receita 5A)
-8.2%
—
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
BGLC
Mediana de Pares
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 15
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7M | $10M | $10M | $11M | $13M | $11M | $127.0K | $212.3K | |
| Cost of Revenue | $6M | $8M | $8M | $10M | $11M | $10M | $71.1K | $-183.6K | |
| Gross Profit | $1M | $1M | $1M | $1M | $2M | $2M | $55.9K | $28.8K | |
| R&D Expense | $50.7K | $47.5K | $55.0K | · | · | · | · | · | |
| SG&A Expense | $2M | $2M | $2M | $2M | $1M | $1M | $356.6K | $-241.9K | |
| Operating Expenses | $4M | $5M | $-4M | · | · | · | · | · | |
| Operating Income | $-3M | $-2M | $-3M | $-291.2K | $1M | $1M | $-275.7K | $59.9K | |
| Interest Expense | · | · | $13.9K | $12.5K | · | · | · | · | |
| Other Non-op | $432.1K | $2M | $486.0K | · | · | · | $29.2K | $-33.4K | |
| Pretax Income | $-3M | $-2M | $-3M | $-303.7K | $1M | · | · | · | |
| Income Tax | $0 | $-3.5K | $-21.5K | $-52.3K | $-291.3K | · | $24.8K | $-33.4K | |
| Net Income | $-3M | $-2M | $-3M | $-356.0K | $751.6K | $1M | $-246.5K | $26.5K | |
| EPS (Diluted) | · | $-0.09 | $-0.17 | · | · | · | · | · | |
| Shares (Diluted) | · | 17,818,483 | 15,875,455 | · | · | · | · | · | |
| EBITDA | $-3M | · | · | · | $1M | $1M | $-275.7K | · |
Balanço Patrimonial 22
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $3M | $3M | $611.8K | $578.5K | $3M | $859.1K | $1M | |
| Receivables | $505.9K | $1M | · | · | · | · | · | · | |
| Inventory | $676.7K | $1M | $1M | $977.8K | $2M | $1M | $7.6K | $15.3K | |
| Other Current Assets | $83.3K | $0 | · | · | · | · | · | · | |
| Current Assets | $5M | $7M | $8M | $6M | $7M | $8M | $882.6K | $1M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $2M | $312.9K | $341.8K | |
| PP&E (Gross) | $3M | $3M | $2M | $2M | $2M | · | $405.0K | $395.5K | |
| Accum. Depreciation | $868.8K | $757.0K | $659.1K | $616.9K | $525.6K | · | $98.2K | $56.5K | |
| Total Assets | $9M | $10M | $11M | $9M | $10M | $10M | $1M | $2M | |
| Accounts Payable | · | $2M | $1M | $2M | $2M | · | · | · | |
| Accrued Liabilities | $126.0K | $168.8K | · | · | · | · | · | · | |
| Current Liabilities | $521.0K | $2M | $2M | $2M | $2M | $3M | $51.6K | $62.9K | |
| Capital Leases | $116.9K | $159.7K | $98.8K | $40.2K | $24.6K | $42.4K | $12.2K | · | |
| Deferred Tax | · | $0 | $12.3K | $30.9K | $28.4K | · | · | · | |
| Total Liabilities | $637.9K | $2M | $2M | $2M | $2M | $3M | $108.9K | $130.3K | |
| Common Stock | $20M | $17M | $17M | $11M | $11M | $11M | $6M | $7M | |
| Paid-in Capital | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | |
| Retained Earnings | $-6M | $-3M | $-2M | $1M | $2M | $760.8K | $-333.3K | $-86.8K | |
| AOCI | $-120.7K | $-555.0K | $-677.3K | $-409.1K | $-100.3K | $133.7K | $-17.1K | $-27.0K | |
| Stockholders' Equity | $9M | $8M | $10M | $7M | $7M | $7M | $1M | $2M | |
| Liabilities + Equity | $9M | $10M | $11M | $9M | $10M | $10M | $1M | $2M | |
| Shares Outstanding | 2,417,314 | 1,796,766 | 17,667,663 | 14,476,513 | 171,218,152 | 171,218,152 | 102,730,891 | 74,627,558 |
Fluxo de Caixa 12
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | $41.7K | $40.6K | |
| Stock-based Comp | $794.8K | $141.0K | · | · | · | · | · | · | |
| Deferred Tax | $0 | $12.3K | $17.4K | $-3.9K | $-26.7K | $1.2K | $4.5K | · | |
| Operating Cash Flow | $-2M | $-2M | $-2M | $551.8K | $9.2K | $552.7K | $-217.3K | $-274.1K | |
| CapEx | $37.0K | $227.0K | $149.4K | $0 | $3.2K | $421.6K | $12.8K | $-39.6K | |
| Investing Cash Flow | $944.8K | $418.2K | $-2M | $-450.5K | $-490.6K | $1M | $-12.8K | $-51.7K | |
| Stock Issued | · | · | · | · | · | · | $-163.0K | $741.5K | |
| Net Stock Activity | · | · | · | · | · | · | $-163.0K | · | |
| Financing Cash Flow | $298.8K | $4.0K | $6M | $108.2K | $-28.2K | $-4.9K | $-180.8K | $742.9K | |
| Net Change in Cash | $-400.6K | $-2M | $2M | $-5.1K | $-663.8K | · | · | · | |
| Taxes Paid | $-14.8K | $-40.4K | $-67.0K | $-170.4K | $-226.8K | $-143.5K | $-10.7K | · | |
| Free Cash Flow | $-2M | · | · | · | $6.0K | $131.1K | $-204.5K | · |
Lucratividade 8
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 14.6% | · | · | · | 16.4% | 15.1% | 44.0% | · | |
| Operating Margin | -39.9% | · | · | · | 7.9% | 11.2% | -217.2% | · | |
| Net Margin | -40.2% | · | · | · | 5.6% | 9.6% | -194.1% | · | |
| Pretax Margin | -40.2% | · | · | · | · | · | · | · | |
| EBITDA Margin | -39.9% | · | · | · | 7.9% | 11.2% | -217.2% | · | |
| ROA | -30.3% | · | · | · | 7.6% | 19.3% | -17.1% | · | |
| ROE | -37.0% | · | · | · | 10.6% | 16.4% | -19.6% | · | |
| ROIC | -34.4% | · | · | · | · | · | · | · |
Liquidez e Solvência 2
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.5 | · | · | · | 3.1 | 2.4 | 17.1 | · | |
| Quick Ratio | 5.7 | · | · | · | 0.9 | 0.8 | 7.1 | · |
Eficiência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | · | · | · | 1.4 | 2.0 | 0.1 | · | |
| Inventory Turnover | 6.1 | · | · | · | 8.3 | 16.3 | -6.2 | · | |
| Receivables Turnover | 7.9 | · | · | · | · | · | · | · |
Taxas de Crescimento 4
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -21.9% | -2.7% | -10.6% | -18.2% | 17.3% | · | · | · | |
| Revenue CAGR 3Y | -12.1% | -10.7% | -5.0% | · | · | · | · | · | |
| Revenue CAGR 5Y | -8.2% | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | · | -31.3% | · | · | · |
Avaliação (TTM) 10
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | $10M | $10M | $11M | $13M | $11M | $127.0K | · | |
| Net Income TTM | $-3M | $-2M | $-3M | $-356.0K | $751.6K | $1M | $-246.5K | · | |
| Market Cap | $10M | · | · | · | $43.76B | · | · | · | |
| P/E | -2.6 | -31.1 | -31.9 | · | · | · | · | · | |
| P/S | 1.3 | · | · | · | 3275.1 | · | · | · | |
| P/B | 1.1 | · | · | · | 6095.4 | · | · | · | |
| P / Tangible Book | 1.1 | 6.0 | 9.7 | 2971.3 | 6095.4 | · | · | · | |
| P / Cash Flow | -5.2 | · | · | · | 4777137.8 | · | · | · | |
| P / FCF | -5.1 | · | · | · | 7295109.1 | · | · | · | |
| Earnings Yield | -38.5% | -3.2% | -3.1% | · | · | · | · | · |
Demonstração de Resultados 15
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $76.2K | $22.8K | $483.8K | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $3M | $3M | $2M | $3M | $3M | |
| Cost of Revenue | $63.2K | $23.6K | $487.7K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | |
| Gross Profit | $13.0K | $-790 | $-4.0K | $377.7K | $368.0K | $343.5K | $309.2K | $326.5K | $288.7K | $365.0K | $266.6K | $354.3K | $339.7K | $368.9K | $339.2K | $299.5K | |
| R&D Expense | $13.7K | $14.5K | $11.1K | $14.9K | $12.6K | $12.1K | $17.4K | $10.4K | $8.2K | $11.5K | · | · | · | · | · | · | |
| SG&A Expense | $298.5K | $327.7K | $181.1K | $445.7K | $516.8K | $391.9K | $165.9K | $792.4K | $558.8K | $315.8K | $-2M | $3M | $807.1K | $536.9K | $487.8K | $418.8K | |
| Operating Expenses | $416.4K | $597.4K | $3M | $1M | $1M | $1M | $3M | $2M | $759.7K | $-645.9K | · | · | · | · | · | · | |
| Operating Income | $-282.4K | $-540.5K | $-1M | $-702.5K | $-611.3K | $-618.4K | $-416.2K | $-1M | $259.2K | $-79.0K | $257.8K | $-3M | $-272.2K | $-50.6K | $-122.7K | $-65.2K | |
| Interest Expense | · | · | · | · | · | · | · | $6.2K | $4.5K | $4.7K | · | $4.3K | $3.0K | $2.4K | $4.8K | $2.1K | |
| Other Non-op | · | $57.7K | $23.5K | $107.8K | $209.5K | $91.4K | $675.0K | $465.5K | $730.1K | $201.8K | · | · | · | · | · | · | |
| Pretax Income | $-286.5K | $-543.6K | $-1M | $-709.0K | $-616.2K | $-623.3K | $-422.0K | $-1M | $254.7K | $-83.7K | $253.6K | $-3M | $-275.2K | $-53.1K | $-127.5K | $-67.3K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $-40.6K | $1.6K | $55.6K | $-20.1K | $-97.9K | $76.4K | $16.0K | $-16.0K | $-75.1K | $10.1K | |
| Net Income | $-286.5K | $-543.6K | $-1M | $-709.0K | $-616.2K | $-623.3K | $-348.3K | $-1M | $199.1K | $-103.8K | $308.5K | $-3M | $-259.3K | $-69.1K | $-157.0K | $-77.4K | |
| EPS (Diluted) | $-0.12 | $-0.23 | · | $-0.40 | $-0.34 | $-0.35 | · | $-0.75 | $0.11 | $-0.01 | · | · | · | · | · | · | |
| Shares (Diluted) | 2,417,314 | 2,417,314 | · | 1,796,597 | 1,796,597 | 1,796,766 | · | 1,796,766 | 1,766,766 | 17,667,663 | · | · | · | · | · | · | |
| EBITDA | $-282.4K | $-540.5K | · | $-702.5K | $-611.3K | $-618.4K | · | $-1M | $259.2K | $-79.0K | · | · | · | · | · | $-65.2K |
Balanço Patrimonial 22
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1M | · | $2M | · | · | · | $3M | · | · | $2M | · | $5M | $297.1K | $406.8K | $611.8K | $478.2K | |
| Receivables | $15.5K | $79.9K | $505.9K | $2M | $2M | · | $1M | · | · | · | · | · | · | · | · | · | |
| Inventory | $652.9K | $667.2K | $676.7K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $899.6K | $977.8K | $1M | |
| Other Current Assets | $583.3K | $333.3K | $83.3K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Current Assets | $5M | $5M | $5M | $6M | $6M | $7M | $7M | $7M | $8M | $8M | $8M | $8M | $5M | $5M | $6M | $5M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $1M | $1M | $1M | $2M | $1M | |
| PP&E (Gross) | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | |
| Accum. Depreciation | $925.2K | $897.1K | $868.8K | $840.4K | $811.4K | $783.6K | $757.0K | $729.2K | $695.0K | $679.3K | $659.1K | $638.4K | $616.0K | $611.2K | $616.9K | $592.2K | |
| Total Assets | $9M | $9M | $9M | $8M | $9M | $9M | $10M | $11M | $11M | $11M | $11M | $11M | $8M | $8M | $9M | $8M | |
| Accounts Payable | · | · | · | · | · | $1M | · | $1M | $954.8K | $1M | $1M | $2M | $2M | $1M | $2M | $1M | |
| Accrued Liabilities | $70.5K | $108.6K | $126.0K | · | · | · | $168.8K | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $812.9K | $796.5K | $521.0K | $678.0K | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | |
| Capital Leases | $89.3K | $103.8K | $116.9K | $126.9K | $141.3K | $147.9K | $159.7K | $178.4K | $182.7K | $88.8K | $98.8K | $104.9K | $29.7K | $35.7K | $40.2K | $14.1K | |
| Deferred Tax | · | · | · | $0 | $0 | $0 | · | $13.6K | $11.9K | $11.9K | $12.3K | $28.9K | $29.0K | $30.7K | $30.9K | $25.5K | |
| Total Liabilities | $948.0K | $946.9K | $637.9K | $805.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | |
| Common Stock | $20M | $20M | $20M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $11M | $11M | $11M | $11M | |
| Paid-in Capital | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | |
| Retained Earnings | $-7M | $-7M | $-6M | $-5M | $-5M | $-4M | $-3M | $-3M | $-2M | $-2M | $-2M | $-2M | $828.1K | $1M | $1M | $1M | |
| AOCI | $-127.2K | $-98.8K | $-120.7K | $-112.5K | $-115.8K | $-482.8K | $-555.0K | $-162.1K | $-884.7K | $-887.2K | $-677.3K | $-800.6K | $-782.0K | $-448.1K | $-409.1K | $-807.4K | |
| Stockholders' Equity | $8M | $8M | $9M | $7M | $8M | $8M | $8M | $9M | $10M | $9M | $10M | $10M | $6M | $7M | $7M | $6M | |
| Liabilities + Equity | $9M | $9M | $9M | $8M | $9M | $9M | $10M | $11M | $11M | $11M | $11M | $11M | $8M | $8M | $9M | $8M | |
| Shares Outstanding | 2,417,314 | 2,417,314 | 2,417,314 | 1,796,597 | 1,796,597 | 17,967,663 | 1,796,766 | 17,967,663 | 17,667,663 | 17,667,663 | 17,667,663 | 17,792,663 | 173,718,152 | 173,718,152 | 14,476,513 | 173,718,152 |
Fluxo de Caixa 9
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | · | · | $794.8K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | $16.0K | · | · | · | |
| Operating Cash Flow | $-422.5K | $-147.7K | $961.1K | $-1M | $-737.9K | $-824.1K | $219.2K | $-2M | $-675.0K | $-37.2K | $-782.5K | $-899.3K | $-22.0K | $-116.5K | $476.7K | $312.7K | |
| CapEx | $250 | $325 | $977 | $5.5K | $21.5K | $9.1K | $4.0K | $199.2K | $1.8K | $21.9K | $937 | $134.0K | $14.4K | $102 | $-37.1K | $3.7K | |
| Investing Cash Flow | $416.1K | $-14.0K | $-5.7K | $994.6K | $-28.5K | $-15.6K | $554.4K | $-243.4K | $42.9K | $3.6K | $-1M | $-360.7K | $-3.1K | $-5.1K | $-49.9K | $18.4K | |
| Financing Cash Flow | $13.6K | $59.7K | $266.5K | $34.2K | $-1.0K | $-860 | $-142.4K | $-51.4K | $178.1K | $26.9K | $531.7K | $6M | $-2.4K | $-1.8K | $-2.3K | $-5.5K | |
| Net Change in Cash | $-6.0K | $-88.4K | $1M | $-180.1K | $-552.2K | $-797.5K | $221.6K | $-1M | $-458.3K | $-79.0K | $-2M | $4M | $-214.5K | $-145.7K | $-666.7K | $1M | |
| Taxes Paid | $0 | $0 | $-154 | $-2.2K | $-7.6K | $-4.9K | $-538 | $-13.1K | $-12.3K | $-14.5K | $-19.2K | $-17.2K | $-18.2K | $-12.4K | $-294.0K | $50.1K | |
| Free Cash Flow | · | $-148.0K | · | · | · | $-833.1K | · | · | · | · | · | · | · | · | · | · |
Lucratividade 8
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 17.1% | -3.5% | · | 14.8% | 16.3% | 16.1% | · | 12.4% | 14.6% | 15.3% | · | · | · | · | · | 11.6% | |
| Operating Margin | -370.8% | -2366.2% | · | -27.6% | -27.1% | -28.9% | · | -50.8% | 13.1% | -3.3% | · | · | · | · | · | -2.5% | |
| Net Margin | -376.1% | -2379.7% | · | -27.9% | -27.3% | -29.2% | · | -51.1% | 10.1% | -4.4% | · | · | · | · | · | -3.0% | |
| Pretax Margin | -376.1% | -2379.7% | · | -27.9% | -27.3% | -29.2% | · | -51.1% | 12.9% | -3.5% | · | · | · | · | · | -2.6% | |
| EBITDA Margin | -370.8% | -2366.2% | · | -27.6% | -27.1% | -28.9% | · | -50.8% | 13.1% | -3.3% | · | · | · | · | · | -2.5% | |
| ROA | -3.2% | -5.9% | · | -7.6% | -6.0% | -6.0% | · | -12.0% | 2.1% | -1.1% | · | · | · | · | · | -0.88% | |
| ROE | -3.7% | -6.9% | · | -8.8% | -7.2% | -7.3% | · | -14.1% | 2.6% | -1.3% | · | · | · | · | · | -1.1% | |
| ROIC | -3.6% | -6.7% | · | -10.3% | -8.1% | -8.0% | · | -14.3% | 3.3% | -0.64% | · | · | · | · | · | -1.2% |
Liquidez e Solvência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | 6.5 | · | 8.3 | 3.6 | 4.2 | · | 5.0 | 5.6 | 4.6 | · | · | · | · | · | 4.1 | |
| Quick Ratio | 1.5 | 0.1 | · | 2.2 | 1.1 | · | · | · | · | 1.5 | · | · | · | · | · | 0.4 | |
| Interest Coverage | · | · | · | · | · | · | · | -216.0 | · | -17.0 | · | · | · | · | · | · |
Eficiência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.3 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | · | · | · | · | 0.3 | |
| Inventory Turnover | 0.1 | 0.0 | · | 1.8 | 1.7 | 1.6 | · | 1.8 | 1.5 | 2.0 | · | · | · | · | · | 1.8 | |
| Receivables Turnover | 0.1 | 0.6 | · | 3.3 | 2.4 | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 10
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5M | $7M | · | $10M | $9M | $9M | · | $10M | $9M | $10M | · | $10M | $10M | $10M | · | $12M | |
| Net Income TTM | $-2M | $-2M | · | $-3M | $-2M | $-2M | · | $-4M | $-3M | $-3M | · | $-3M | $-544.4K | $-268.1K | · | $96.3K | |
| Market Cap | $5M | $5M | · | $10M | $6M | $42M | · | $80M | $84M | $125M | · | · | · | · | · | $22.10B | |
| P/E | -1.8 | -1.6 | · | -3.6 | -3.0 | -3.5 | · | · | · | · | · | · | · | · | · | · | |
| P/S | 1.0 | 0.7 | · | 1.0 | 0.6 | 4.6 | · | 8.4 | 8.9 | 12.6 | · | · | · | · | · | 1894.3 | |
| P/B | 0.6 | 0.6 | · | 1.4 | 0.7 | 5.5 | · | 8.5 | 8.8 | 13.3 | · | · | · | · | · | 3439.9 | |
| P / Tangible Book | 0.6 | 0.6 | · | 1.4 | 0.7 | 5.5 | · | 8.5 | 8.8 | 13.3 | · | 16.0 | 772.5 | 1716.8 | · | 3439.9 | |
| P / Cash Flow | · | -35.0 | · | · | · | -51.5 | · | · | · | -3621.6 | · | · | · | · | · | · | |
| P / FCF | · | -35.0 | · | · | · | -50.9 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -55.4% | -61.2% | · | -27.8% | -33.0% | -28.7% | · | · | · | · | · | · | · | · | · | · |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $7M | $10M | $10M | $11M | $13M |
| Margem Bruta % | 14.6% | — | — | — | 16.4% |
| Margem Operacional % | -39.9% | — | — | — | 7.9% |
| Lucro líquido | $-3M | $-2M | $-3M | $-356.0K | $751.6K |
| EPS Diluído | — | $-0.09 | $-0.17 | — | — |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 10.5 | — | — | — | 3.1 |
| Índice de Liquidez Seca | 5.7 | — | — | — | 0.9 |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $-2M | — | — | — | $6.0K |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 3 declarantes · $31 total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 2 | 1 | 0 | 1 | — |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado. Variação vs trimestre anterior não mostrada: a cobertura de registrantes difere demais entre esses dois trimestres para uma comparação confiável.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| HRT FINANCIAL LP | $27 | 14.283 | 87,10% | Ações |
| UBS Group AG | $2 | 1 | 6,45% | Ações |
| Caitong International Asset Management Co., Ltd | $2 | 1 | 6,45% | Ações |
Executivos da empresa 5 insiders · 0 diretores · 0 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Jook Yuen Low | — | 13 de Agosto de 2026 A | 17.390 | 0 | 0 | $0 |
| Lee Su-Leng Tan | — | 13 de Agosto de 2026 A | 338.709 | 0 | 0 | $0 |
| Abdul Hamid Muhammad Azrul Bin | — | 13 de Agosto de 2026 A | 32.258 | 0 | 0 | $0 |
| Set Fui Chong | — | 13 de Agosto de 2026 A | 96.774 | 0 | 0 | $0 |
| Chee Keong Yap | — | 13 de Agosto de 2026 A | 32.258 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 2 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Tan Lee Su-Leng | 14 de Agosto de 2026 | 11,50% | Declaração inicial | — | SEC |
| Soo Kow Lai, Chan Chong Wong, Liong Tai Tan, Too Kam Tham, Kim Hai Wong | 17 de Janeiro de 2024 | — | Declaração inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.